alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

112TH CONGRESS 

1ST SESSION H. R. 1985 

To amend the Internal Revenue Code of 1986 to allow a deduction for 

expenses in connection with the trade or business of selling marijuana 

intended for patients for medical purposes pursuant to State law. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 25, 2011 

Mr. STARK (for himself, Mr. ROHRABACHER, Mr. POLIS, Mr. PAUL, and Mr. 

FRANK of Massachusetts) introduced the following bill; which was referred to the Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to allow a 

deduction for expenses in connection with the trade or 

business of selling marijuana intended for patients for 

medical purposes pursuant to State law. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Small Business Tax 

5 Equity Act of 2011’’. 


emcdonald on DSK2BSOYB1PROD with BILLS
2 

•HR 1985 IH

1 SEC. 2. DEDUCTION ALLOWED FOR EXPENSES IN CONNEC2 TION WITH SALES OF MARIJUANA. 

3 (a) IN GENERAL.—Section 280E of the Internal Rev4 enue Code of 1986 is amended— 

5 (1) by striking ‘‘No deduction’’ and inserting 

6 ‘‘(a) IN GENERAL.—No deduction’’, and 

7 (2) by adding at the end the following new sub8 section: 

9 ‘‘(b) EXCEPTION.—Subsection (a) shall not apply to 

10 amounts paid or incurred in connection with the portion 

11 of the trade or business consisting of sales of marihuana 

12 (as defined by section 102(16) of the Controlled Sub13 stances Act) intended for patients for medical purposes 

14 pursuant to the law of a State.’’. 

15 (b) EFFECTIVE DATE.—The amendments made by 

16 subsection (a) shall apply to amounts paid or incurred 

17 after the later of— 

18 (1) the date of the enactment of this Act, or 

19 (2) the date on which the State law referred to 

20 in section 280E(b) of the Internal Revenue Code of 

21 1986 (as added by subsection (a)) is first effective. 

Æ 


emcdonald on DSK2BSOYB1PROD with BILLS
I 

112TH CONGRESS 

1ST SESSION H. R. 1990 

To expand the boundary of Saguaro National Park, to study additional 

land for future adjustments to the boundary of the Park, and for other 

purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 25, 2011 

Mr. GRIJALVA introduced the following bill; which was referred to the 

Committee on Natural Resources 

A BILL 

To expand the boundary of Saguaro National Park, to study 

additional land for future adjustments to the boundary 

of the Park, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Saguaro National Park 

5 Boundary Expansion and Study Act of 2011’’. 

6 SEC. 2. BOUNDARY OF SAGUARO NATIONAL PARK. 

7 Section 4 of the ‘‘Saguaro National Park Establish8 ment Act of 1994’’ (Public Law 103–364, 108 Stat. 

9 3467), is amended— 


jlentini on DSK4TPTVN1PROD with BILLS
2 

•HR 1990 IH

1 (1) in subsection (a)— 

2 (A) by inserting ‘‘(1)’’ before ‘‘The bound3 aries of the park’’; and 

4 (B) by adding at the end the following: 

5 ‘‘(2) The boundary of the park is further modi6 fied to include approximately 975 acres, as generally 

7 depicted on the map titled ‘Saguaro National Park 

8 Proposed Boundary Adjustment’, numbered 151/ 

9 80,045A, and dated August 2008. The map shall be 

10 on file and available for inspection in the appro11 priate offices of the National Park Service.’’; 

12 (2) by striking subsection (b)(2) and inserting 

13 the following new paragraphs: 

14 ‘‘(2) The Secretary may, with the consent of 

15 the State and in accordance with Federal and State 

16 law, acquire from the State land or interests in land 

17 within the boundary of the park. 

18 ‘‘(3) If the Secretary is unable to acquire the 

19 State land under paragraph (2), the Secretary may 

20 enter into an agreement that would allow the Na21 tional Park Service to manage State land within the 

22 boundary of the park.’’; and 

23 (3) by adding at the end the following new sub24 section: 

25 ‘‘(d) BOUNDARY STUDY.— 


jlentini on DSK4TPTVN1PROD with BILLS
3 

•HR 1990 IH

1 ‘‘(1) IN GENERAL.—The Secretary shall con2 duct a study to identify lands that would be a part 

3 of any future boundary adjustments for the park. 

4 ‘‘(2) CRITERIA.—The study shall examine the 

5 natural, cultural, recreational, and scenic values and 

6 characters of lands identified under paragraph (1). 

7 ‘‘(3) REPORT.—Not later than 2 years after the 

8 date funds are made available for the study under 

9 this subsection, the Secretary shall submit to the 

10 Committee on Natural Resources of the House of 

11 Representatives and the Committee on Energy and 

12 Natural Resources of the Senate a report on the 

13 findings, conclusions, and recommendations of the 

14 study.’’. 

Æ 


jlentini on DSK4TPTVN1PROD with BILLS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; AIDS and Cancer Specimen Resource-UM1.                    

*Date:*                         March 20, 2024.                    

*Time:*                         10:00 a.m. to 1:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W126, Rockville, Maryland 20850 (Virtual Meeting).                    

*Contact Person:*                         Mukesh Kumar, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W126, Rockville, Maryland 20850, 240-276-6611,                         *mukesh.kumar3@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

 Dated: February 21, 2024. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-03840 Filed 2-23-24; 8:45 am]

BILLING CODE 4140-01-P
Order entered February 24, 2020

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-19-00893-CV

FELIPE DELEON, JR., Appellant

V.

ROSA BENITEZ, Appellee

On Appeal from the 292nd Judicial District Court

Dallas County, Texas

Trial Court Cause No. CV97-00151-S

ORDER

Before the Court is appellant’s request for a copy of his November 12, 2020 

“pleading to jurisdiction with exhibits and affidavit in support of brief.” We 

GRANT the request and DIRECT the Clerk of the Court to mail appellant a copy 

of the jurisdictional brief.

We note we questioned our jurisdiction over this appeal because the clerk’s 

record did not contain a copy of the challenged order, and the trial court clerk 

informed the Court the order did not exist. Appellant provided the Court a copy of 
the order in his jurisdictional brief and, on January 29, 2020, a supplemental 

clerk’s record containing a copy of that order was filed. 

Having reviewed the order, which was signed July 8 2019 and dismissed for 

want of jurisdiction appellant’s motion for new trial on a protective order that 

dissolved on its own terms in February 1998, we now question our jurisdiction to 

the extent the appeal appears untimely. See Brashear v. Victoria Gardens of 

McKinney, L.L.C., 302 S.W.3d 542, 545 (Tex. App.—Dallas 2009, no pet.) (op. on 

reh’g) (timely filing of notice of appeal is jurisdictional).

Generally, an appeal is taken from a final judgment, not the refusal to 

reconsider that judgment, and must be filed within thirty days of the date the 

judgment is signed or, with a timely filed motion for new trial, within ninety days 

of judgment. See TEX. R. APP. P. 26.1, 26.1(a). A motion for new trial is timely if 

filed within thirty days of the date of judgment. See TEX. R. CIV. P. 329b(a). Here, 

the judgment was signed February 20, 1997, but the motion for new trial and 

notice of appeal were not filed until over twenty years later, in June and July 2019, 

respectively.

Accordingly, we ORDER appellant to file, no later than March 6, 2020, a 

letter brief addressing the timeliness of the appeal. Any response to appellant’s 

letter brief must be filed within ten days of the letter brief’s filing. If any party 
relies on information not included in the clerk’s record, that party shall have filed a 

supplemental clerk’s record containing that information.

Until the Court determines its jurisdiction, no action will be taken on the 

reporter’s record. The Court will address the status of the reporter’s record should 

it determine it has jurisdiction over the appeal. Should the Court determine it lacks 

jurisdiction, the Court will dismiss the appeal without further notice. See TEX. R.

APP. P. 42.3(a). The Court may also dismiss the appeal without further notice 

should appellant fail to file the requested letter brief. See id. 42.3(a),(c).

/s/ KEN MOLBERG 

JUSTICE
Fourth Court of Appeals

San Antonio, Texas

JUDGMENT

No. 04-15-00472-CV

In the Interest of J.V. Jr., A.A.V., N.V., S.L.V., M.A.T., E.J.V., J.F.V., Children

From the 131st Judicial District Court, Bexar County, Texas

Trial Court No. 2014-PA-00998

Honorable Richard Garcia, Judge Presiding

BEFORE JUSTICE ANGELINI, JUSTICE ALVAREZ, AND JUSTICE PULLIAM

In accordance with this court’s memorandum opinion of this date, the trial court’s 

termination order is AFFIRMED.

SIGNED December 9, 2015.

_____________________________

Karen Angelini, Justice
EXHIBIT 32



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Sino-Biotics, Inc., a Delaware corporation (the Company) on Form 10-QSB for the period ending June 30, 2006, as filed with the Securities and Exchange Commission on the date hereof (the Report), Curtis Hunsinger, President, Chief Executive Officer, Chief Operations Officer (Principal Executive Officer) and Sole Director of the Company, certifies to the best of his knowledge, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:



(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



A signed original of this written statement required by Section 906 has been provided to Sino-Biotics, Inc., and will be retained by Sino-Biotics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.







/s/   Curtis Hunsinger

Curtis Hunsinger, President, Chief Executive

Officer, Chief Operations Officer (Principal

Executive Officer), Sole Director





Date: August 14, 2006
<PAGE>

                                                                      EXHIBIT 23

                         INDEPENDENT AUDITORS' CONSENT

The Board of Directors
OSI Pharmaceuticals, Inc.:

     We consent to the incorporation by reference in the registration statements
on Forms S-3 (No. 333-86624 and 333-57784) and on Forms S-8 (No. 333-91118,
333-65072, No. 333-42274, No. 333-39509, No. 333-06861, No. 33-64713, No.
33-60182, No. 33-38443, and No. 33-8980) of OSI Pharmaceuticals, Inc. of our
report dated November 17, 2003, with respect to the consolidated balance sheets
of OSI Pharmaceuticals, Inc. and subsidiaries as of September 30, 2003 and 2002,
and the related consolidated statements of operations, stockholders' equity and
cash flows for each of the years in the three-year period ended September 30,
2003, which report appears in the September 30, 2003 annual report on Form 10-K
of OSI Pharmaceuticals, Inc.

     As discussed in notes 1(j) and 8 to the consolidated financial statements,
the Company fully adopted the provisions of Statement of Financial Accounting
Standards ("SFAS") No. 142, "Goodwill and Other Intangible Assets" in 2003 and
adopted provisions of SFAS No. 141, "Business Combinations" and SFAS No. 142,
for acquisitions consummated on or after July 1, 2001.

     As discussed in note 10 to the consolidated financial statements, the
Company early adopted Statement of Financial Accounting Standards No. 145
"Rescission of FASB Statements No. 4, 44 and 64, Amendment of FASB Statement No.
13, and Technical Corrections" relating to the classification of the effect of
early debt extinguishments in 2002.

                                          /s/ KPMG LLP

Melville, New York
December 1, 2003
#### CORNEL CALINESCU *v.*CFD ASSOCIATES ET AL.

(14773)

Dupont, C. J., and Lavery and Heiman, Js.

Submitted on briefs December 14,1995

decision released January 23, 1996

*913
      *Brian S. Karpe*filed a brief for the appellant (plaintiff).

*David W. Schoolcraft*filed a brief for the appellees (defendants).

PER CURIAM.

The judgment is affirmed.
| **GENERAL (Details)**            | 9 Months Ended |
|----------------------------------|----------------|
||
| **Fiscal Period [Line Items]**   |           |
| Fiscal Year Minimum Week Period  | 1 year         |
| Fiscal Year Maximum Weeks Period | 1 year 7 days  |

| X                                                                                                                                                                                                                               |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Fiscal Period [Line Items]
+ References
No definition available.
+ Details**Name:**pvh_FiscalPeriodLineItems**Namespace Prefix:**pvh_**Data Type:**xbrli:stringItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                     |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Maximum weeks comprising the Company's fiscal year ending on the Sunday closest to February 1.
+ References
No definition available.
+ Details**Name:**pvh_FiscalYearMaximumWeeksPeriod**Namespace Prefix:**pvh_**Data Type:**us-types:durationStringItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                    |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Minimum weeks comprising the Company's fiscal year ending on the Sunday closest to February 1.
+ References
No definition available.
+ Details**Name:**pvh_FiscalYearMinimumWeekPeriod**Namespace Prefix:**pvh_**Data Type:**us-types:durationStringItemType**Balance Type:**na**Period Type:**duration |
Exhibit 31.1

                            CERTIFICATION PURSUANT TO
                SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002
I, David Mintz, certify that:

1. I have reviewed this annual report on Form 10-KSB/A of Tofutti Brands Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 15(e) and 15d- 15(e)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

(b) [Paragraph omitted pursuant to SEC Release Nos. 33-8238 and 34-47986]

(c) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control
over financial reporting that occurred during the registrant's most recent
fiscal quarter (the registrant's fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent function):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date: June 22, 2004

/s/David Mintz*
---------------
David Mintz
Chief Executive Officer

* The originally executed copy of this Certification will be maintained at the
Company's offices and will be made available for inspection upon request.
```

[Federal Register Volume 79, Number 191 (Thursday, October 2, 2014)]
[Notices]
[Page 59549]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23535]

-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice: 8890]

In the Matter of the Designation of Nusret Imamovic, also known 
as Nusret Sulejman Imamovic as a Specially Designated Global Terrorist 
pursuant to Section 1(b) of Executive Order 13224, as Amended

    Acting under the authority of and in accordance with section 1(b) 
of Executive Order 13224 of September 23, 2001, as amended by Executive 
Order 13268 of July 2, 2002, and Executive Order 13284 of January 23, 
2003, I hereby determine the individual known as Nusret Imamovic, also 
known as Nusret Sulejman Imamovic, committed, or poses a significant 
risk of committing, acts of terrorism that threaten the security of 
U.S. nationals or the national security, foreign policy, or economy of 
the United States.
    Consistent with the determination in section 10 of Executive Order 
13224 that ``prior notice to persons determined to be subject to the 
Order who might have a constitutional presence in the United States 
would render ineffectual the blocking and other measures authorized in 
the Order because of the ability to transfer funds instantaneously,'' I 
determine no prior notice needs to be provided to any person subject to 
this determination who might have a constitutional presence in the 
United States, because to do so would render ineffectual the measures 
authorized in the Order.
    This notice shall be published in the Federal Register.

    Dated: September 23, 2014.
John F. Kerry,
Secretary of State.
[FR Doc. 2014-23535 Filed 10-1-14; 8:45 am]
BILLING CODE 4710-05-P
```
<PAGE>


                                                                    EXHIBIT 99.1

                                  CERTIFICATION

     To my knowledge, this Report on Form 10-Q for the quarter ended June 30,
2002 fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and the information contained in this Report
fairly presents, in all material respects, the financial condition and results
of operations of Genuity Inc.



                                       GENUITY INC.



                                       By: /s/ Paul R. Gudonis
                                          -----------------------------------
                                                    Paul R. Gudonis
                                          CHAIRMAN AND CHIEF EXECUTIVE OFFICER
                                               (DULY AUTHORIZED OFFICER)



                                       By: /s/ Daniel P. O'Brien
                                          ------------------------------------
                                                   Daniel P. O'Brien
                                               EXECUTIVE VICE PRESIDENT
                                              AND CHIEF FINANCIAL OFFICER
                                               (DULY AUTHORIZED OFFICER)


Dated: August 14, 2002